U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(h) of the Investment Company Act of 1940
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5
obligations may continue. See Instruction 1(b).
________________________________________________________________________________
1. Name and Address of Reporting Person*
Feinberg, Larry N.
- --------------------------------------------------------------------------------
(Last) (First) (Middle)
c/o Oracle Strategic Partners, L.P.
200 Greenwich Avenue, 3rd Floor
- --------------------------------------------------------------------------------
(Street)
Greenwich, CT 06830
- --------------------------------------------------------------------------------
(City) (State) (Zip)
________________________________________________________________________________
2. Issuer Name and Ticker or Trading Symbol
Halsey Drug Co., Inc. ("HDGC")
________________________________________________________________________________
3. IRS Identification Number of Reporting Person, if an entity (Voluntary)
________________________________________________________________________________
4. Statement for Month/Day/Year
April 10, 2003
________________________________________________________________________________
5. If Amendment, Date of Original (Month/Day/Year)
________________________________________________________________________________
6. Relationship of Reporting Person to Issuer
(Check all applicable)
[ ] Director [X] 10% Owner
[ ] Officer (give title below) [ ] Other (specify below)
------------------------
________________________________________________________________________________
7. Individual or Joint/Group Filing (Check applicable line)
[X] Form filed by one Reporting Person
[ ] Form filed by more than one Reporting Person
________________________________________________________________________________
================================================================================
Table I -- Non-Derivative Securities Acquired, Disposed of,
or Beneficially Owned
================================================================================
5.
Amount of 6.
4. Securities Owner-
2. 2A. 3. Securities Acquired (A) or Beneficially ship
Trans- Deemed Trans- Disposed of (D) Owned Form: 7.
action Execution action (Instr. 3, 4 and 5) Following Direct Nature of
Date Date, if any Code ----------------------------- Reported (D) or Indirect
1. (Month/ (Month/ (Instr. 8) (A) Transaction(s) Indirect Beneficial
Title of Security Day/ Day/ ---------- Amount or Price (Instr. 3 (I) Ownership
(Instr. 3) Year) Year) Code V (D) and 4) (Instr.4) (Instr. 4)
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
====================================================================================================================================
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the Form is filed by more than one Reporting Person, see Instruction 4(b)(v).
Persons who are to respond to the collection of information contained in this form are not required to respond unless the form
displays a currently valid OMB control number.
Page 1 of 2
FORM 4 (continued)
Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
================================================================================
5. 7.
Number of Title and Amount
Derivative 6. of Underlying
4. Securities Date Securities
2. 3A. Trans- Acquired (A) Exercisable and (Instr. 3 and 4)
Conver- Deemed action or Disposed Expiration Date ----------------
1. sion or 3. Execution Code of(D) (Month/Day/Year) Amount
Title of Exercise Trans- Date, (Instr. (Instr. 3, ---------------- or
Derivative Price of action Date if any 8) 4 and 5) Date Expira- Number
Security Derivative (Month/ (Month/ ------ ------------ Exer- tion of
(Instr. 3) Security Day/Year) Day/Year) Code V (A) (D) cisable Date Title Shares
- ------------------------------------------------------------------------------------------------------------------------------------
5% Convertible Senior $0.9250 04/10/03 J(2) 1 Immed. 3/31/06 Common 156,858
Secured Debentures Stock
- ------------------------------------------------------------------------------------------------------------------------------------
====================================================================================================================================
[TABLE CONTINUED BELOW]
[CONTINUATION OF TABLE FROM ABOVE]
9.
Number of 10.
Derivative Ownership
Securities Form of 11.
8. Beneficially Derivative Nature
Price of Owned Follow- Security of Indirect
Derivative ing Reported Direct (D) or Beneficial
Security Transaction(s) Indirect (I) Ownership
(Instr. 5) (Instr. 4) (Instr. 4) (Instr. 4)
- ---------------------------------------------------------
See Note 14 I See Note (1)
(2) under under
Explanation Explanation
of of Responses
Responses below.
below.
- ---------------------------------------------------------
=========================================================
Explanation of Responses:
(1) The securities of Halsey Drug Co., Inc. ("Halsey") to which this note relates are held directly by Oracle Strategic Partners,
L.P. ("Strategic Partners"). Strategic Partners holds, as of the date of this Form 4, 3,649,461 shares of Common Stock of the
Company ("Common Stock") as well as Options for Common Stock ("Options") and 5% Convertible Senior Secured Debentures
("Debentures") presently convertible into 30,000 shares of Common Stock and 19,082,642 shares of Common Stock, respectively.
Oracle Strategic Capital, L.L.C. ("Strategic Capital") serves as the general partner of Strategic Partners. The undersigned is
the managing member of Strategic Capital. The undersigned does not directly own any shares of Common Stock, Options or
Debentures. In accordance with Instruction 4(b)(iv), the entire number of such shares, Options and Debentures held by Strategic
Partners, related to the transactions reported on this Form 4, is reported herein. The undersigned disclaims any beneficial
ownership of the securities to which this Form 4 relates for purposes of Section 16 of the Securities Exchange Act of 1934,
except as to such securities representing the undersigned's pro rata interest in, and interest in the profits of, Strategic
Partners.
(2) The Debenture to which this note relates, in the principal amount of $145,094, was received as interest payment on pre-existing
Debentures held by Strategic Partners. The Debenture to which this note relates is presently convertible into 156,858 shares of
Common Stock of Halsey, reflecting a conversion price of $0.9250 per share of Common Stock. The Debenture to which this note
relates is dated April 1, 2003, however it was not received by Strategic Partners until April 10, 2003.
/s/ Larry N. Feinberg April 14, 2003
- --------------------------------------------- -----------------------
**Signature of Reporting Person Date
Lary N. Feinberg, as managing member of
Oracle Strategic Capital, L.L.C., the general
partner of Oracle Strategic Partners, L.P.
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for
procedure.
Page 2 of 2
